Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 AJR Am J Roentgenol
1 Antiviral Res
11 BMJ
2 Br J Anaesth
5 Clin Chem
1 Clin Infect Dis
2 Emerg Infect Dis
1 Graefes Arch Clin Exp Ophthalmol
3 Infect Control Hosp Epidemiol
11 Int J Infect Dis
16 J Infect
14 J Med Virol
1 J Travel Med
17 Lancet
16 Lancet Infect Dis
6 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
2 Nature
3 Science
3 Travel Med Infect Dis

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. HAO M, Edmonds C, Nachiappan A, Conant E, et al
    Management Strategies for Patients Presenting With Symptomatic Lymphadenopathy and Breast Edema After Recent COVID-19 Vaccination.
    AJR Am J Roentgenol. 2021 Dec 29. doi: 10.2214/AJR.21.27118.
    PubMed         Abstract available

    Antiviral Res

  2. KUMAR R, Khandelwal N, Chander Y, Nagori H, et al
    S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants.
    Antiviral Res. 2021 Dec 27:105232. doi: 10.1016/j.antiviral.2021.105232.
    PubMed         Abstract available


    Condemning consensus is not helpful.
    BMJ. 2021;375:n3073.

    If the NHS falls short on boosters, it won't be for want of trying.
    BMJ. 2021;375:n3106.

  5. HAQUE Z
    Vaccine inequality may undermine the booster programme.
    BMJ. 2021;375:n3118.

    Long covid: research must guide future management.
    BMJ. 2021;375:n3109.

  7. PRUGGER C, Spelsberg A, Keil U, Erviti J, et al
    Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phase.
    BMJ. 2021;375:e067570.

  8. LIMB M
    Covid-19: Self-isolation after infection cut to seven days in England.
    BMJ. 2021;375:n3137.

  9. WHITTAKER HR, Gulea C, Koteci A, Kallis C, et al
    GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study.
    BMJ. 2021;375:e065834.
    PubMed         Abstract available

  10. MIDDLETON J, Lopes H
    With covid-19, single measures aren't enough.
    BMJ. 2021;375:n3157.

  11. KNIGHT M, Vancheeswaran R
    Post-acute covid-19 in primary care.
    BMJ. 2021;375:n3080.

  12. MAHASE E
    Covid-19: Hospital admission 50-70% less likely with omicron than delta, but transmission a major concern.
    BMJ. 2021;375:n3151.

    Covid-19: Early studies give hope omicron is milder than other variants.
    BMJ. 2021;375:n3144.

    Br J Anaesth

  14. POLOK K, Fronczek J, van Heerden PV, Flaatten H, et al
    Association between tracheostomy timing and outcomes for older critically ill COVID-19 patients: prospective observational study in European intensive care units.
    Br J Anaesth. 2021 Nov 29. pii: S0007-0912(21)00756.
    PubMed         Abstract available

  15. MARTINEZ-SIMON A, Honorato-Cia C, Cacho-Asenjo E, Aquerreta I, et al
    COVID-19 publications in anaesthesiology journals: a bibliometric analysis.
    Br J Anaesth. 2021 Dec 9. pii: S0007-0912(21)00769.

    Clin Chem

  16. BOEHRINGER HR, O'Farrell BJ
    Lateral Flow Assays in Infectious Disease Diagnosis.
    Clin Chem. 2021;68:52-58.
    PubMed         Abstract available

    Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance.
    Clin Chem. 2021;68:83-90.
    PubMed         Abstract available

  18. BERNA AZ, Odom John AR
    Breath Metabolites to Diagnose Infection.
    Clin Chem. 2021;68:43-51.
    PubMed         Abstract available

  19. TRAN NK, Albahra S, May L, Waldman S, et al
    Evolving Applications of Artificial Intelligence and Machine Learning in Infectious Diseases Testing.
    Clin Chem. 2021;68:125-133.
    PubMed         Abstract available

  20. NUZZO JB
    The United States' SARS-CoV-2 Testing Challenges Underscore the Need to Improve Surveillance Ahead of the Next Health Security Crisis.
    Clin Chem. 2021;68:30-32.

    Clin Infect Dis

  21. YAMAMOTO S, Maeda K, Matsuda K, Tanaka A, et al
    COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study.
    Clin Infect Dis. 2021 Dec 24. pii: 6482345. doi: 10.1093/cid/ciab1048.
    PubMed         Abstract available

    Emerg Infect Dis

  22. FOX-LEWIS A, Williamson F, Harrower J, Ren X, et al
    Airborne Transmission of SARS-CoV-2 Delta Variant within Tightly Monitored Isolation Facility, New Zealand (Aotearoa).
    Emerg Infect Dis. 2021;28.
    PubMed         Abstract available

  23. NICOLETE VC, Rodrigues PT, Fernandes ARJ, Corder RM, et al
    Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020-2021.
    Emerg Infect Dis. 2021;28.
    PubMed         Abstract available

    Graefes Arch Clin Exp Ophthalmol

  24. PENKAVA J, Muenchhoff M, Badell I, Osterman A, et al
    Detection of SARS-CoV-2-RNA in post-mortem samples of human eyes.
    Graefes Arch Clin Exp Ophthalmol. 2021 Dec 28. pii: 10.1007/s00417-021-05529.
    PubMed         Abstract available

    Infect Control Hosp Epidemiol

  25. EVANS CT, DeYoung BJ, Gray EL, Wallia A, et al
    COVID-19 vaccine intentions and uptake in a tertiary care healthcare system: A longitudinal study.
    Infect Control Hosp Epidemiol. 2021 Dec 27:1-19. doi: 10.1017/ice.2021.
    PubMed         Abstract available

  26. ZIEGLER MJ, Huang E, Bekele S, Reesey E, et al
    Spatial and temporal effects on SARS-CoV-2 contamination of the healthcare environment.
    Infect Control Hosp Epidemiol. 2021 Dec 27:1-16. doi: 10.1017/ice.2021.
    PubMed         Abstract available

  27. SHAIKH TG, Waseem S, Ahmed SH, Asghar MS, et al
    Disproportionate distribution of COVID-19 antiviral pills: vaccine inequity replay?
    Infect Control Hosp Epidemiol. 2021 Dec 27:1-6. doi: 10.1017/ice.2021.

    Int J Infect Dis

  28. JAHAN N, Brahma A, Kumar MS, Bagepally BS, et al
    Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020-August 2021: a systematic review and meta-analysis.
    Int J Infect Dis. 2021 Dec 27. pii: S1201-9712(21)01251.
    PubMed         Abstract available

  29. CLAISE C, Saleh J, Rezek M, Vaulont S, et al
    Low Transferrin Levels Predict Heightened Inflammation in COVID-19 Patients: New Insights.
    Int J Infect Dis. 2021 Dec 21. pii: S1201-9712(21)01237.
    PubMed         Abstract available

  30. HOEFER A, Pampaka D, Castrillejo D, Luenga-Cabrera J, et al
    Considerations for COVID-19 management in reception centers for refugees, asylum seekers and migrants, Spain 2020.
    Int J Infect Dis. 2021 Dec 21. pii: S1201-9712(21)01240.
    PubMed         Abstract available

  31. MCKINNON JE, Wang DD, Zervos M, Saval M, et al
    Safety and Tolerability of Hydroxychloroquine in healthcare workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study.
    Int J Infect Dis. 2021 Dec 22. pii: S1201-9712(21)01243.
    PubMed         Abstract available

  32. O'FEE JR, Li J, Chang JR
    Bell's Phenomenon is a normal finding, distinct from Bell's Palsy; Response to "Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database" by Sato et al.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01246.

  33. LIEU A, Mah J, Church D
    A Case of Multisystem Inflammatory Syndrome in Adults Following Natural Infection and Subsequent Immunization.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01239.
    PubMed         Abstract available

  34. CAKMAKLI C, Demiralp S, Ergonul O, Yesiltas S, et al
    The Role of Institutional, Cultural, and Economic Factors on the Effectiveness of the Lockdown Measures.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01233.
    PubMed         Abstract available

  35. AFZAL A, Gutierrez VP, Gomez E, Mon AM, et al
    Bloodstream infections in hospitalized patients before and during the COVID-19 surge in a community hospital in the South Bronx.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01249.

  36. HWANG J, Han YJ, Yon DK, Lee SW, et al
    Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01248.
    PubMed         Abstract available

  37. CHAN EWW, Leung MTY, Lau LKW, Leung J, et al
    Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA Covid-19 vaccine: a prospective cohort study.
    Int J Infect Dis. 2021 Dec 26. pii: S1201-9712(21)01253.
    PubMed         Abstract available

  38. PROMLEK T, Thanunchai M, Phumisantiphong U, Hansirisathit T, et al
    Performance of colorimetric RT-LAMP as a diagnostic tool for SARS-CoV-2 infection during the fourth wave of COVID-19 in Thailand.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01252.
    PubMed         Abstract available

    J Infect

  39. COSTA R, Olea B, Bracho MA, Albert E, et al
    RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00641.

  40. WANG R
    Genetic variation of interleukin-1 receptor type 1 is associated with severity of COVID-19 disease.
    J Infect. 2021 Dec 21. pii: S0163-4453(21)00631.

  41. YAN F, Gao F
    Mutant EK1 with Q1004E/N1006I: a promising fusion inhibitor for the HR1 domain of SARS-CoV-2.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00644.

  42. ORENES-PINERO E, Navas-Carrillo D, Moreno-Docon A, Ortega-Garcia JA, et al
    Confirmation of SARS-CoV-2 airborne dissemination indoors using "COVID-19 traps".
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00630.
    PubMed         Abstract available

  43. GAO P, Zhang X, Zhang S, Yu Y, et al
    COVID-19 persists: Current risk of a recurrence of the epidemic in China.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00643.

  44. MAANI AA, Wahaibi AA, Nazer W, Al-Zadjali N, et al
    The utilization of HCWs surveillance as an early warning of COVID-19 epidemic activity in the community.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00629.

  45. SYED-ABDUL S, Babu AS, Bellamkonda RS, Itumalla R, et al
    Using Artificial Intelligence-based models to predict the risk of Mucormycosis among COVID-19 Survivors: An Experience from a public hospital in India.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00639.
    PubMed         Abstract available

  46. KHURRAM M, Ali G, Awan UA, Afzal MS, et al
    COVID-19 and alarming dengue co-epidemics in the dilapidated healthcare system in Pakistan: Where to focus!
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00638.

  47. COLTELLA L, Ranno S, Piccioni L, Linardos G, et al
    Quantitative SARS-CoV-2 antigen test as a tool able to predict the stage of the infection.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00636.

  48. GENG Y, Zhang L
    The impact of non-pharmaceutical interventions during COVID-19 pandemic on three children infectious diseases in China.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00645.

  49. VINER R, Waddington C, Mytton O, Booy R, et al
    Transmission of SARS-CoV-2 by children and young people in households and schools: a meta-analysis of population-based and contact-tracing studies.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00633.
    PubMed         Abstract available

  50. QIN G, Yang J, Zhao C, Ren J, et al
    The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00634.

  51. RUBESHKUMAR P, John A, Narnaware M, M J, et al
    Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00632.

  52. LAI X, Wang J, Duan J, Gong Y, et al
    Apoptosis inhibitor of macrophage differentiates bacteria from influenza or COVID-19 in hospitalized adults with community-acquired pneumonia.
    J Infect. 2021 Dec 23. pii: S0163-4453(21)00640.

  53. XU B, Ma FQ, He C, Wu ZQ, et al
    Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
    J Infect. 2021 Dec 25. pii: S0163-4453(21)00642.

  54. VENTERO MP, Moreno-Perez O, Molina-Pardines C, Paytuvi-Gallart A, et al
    Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area.
    J Infect. 2021 Dec 25. pii: S0163-4453(21)00647.
    PubMed         Abstract available

    J Med Virol

  55. KERGET B, Kerget F, Aydin M, Karasahin O, et al
    Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID-19.
    J Med Virol. 2021 Dec 27. doi: 10.1002/jmv.27552.
    PubMed         Abstract available

  56. SHAH NN, Dar KA, Quibtiya S, Din Azad AMU, et al
    Repurposing of Mycobacterium indicus pranii for the severe form of COVID -19 patients in India: A cohort study.
    J Med Virol. 2021 Dec 23. doi: 10.1002/jmv.27547.
    PubMed         Abstract available

  57. PAPAROUPA M, Aldemyati R, Roggenkamp H, Berinson B, et al
    The Prevalence of Early- and Late-Onset Bacterial, Viral and Fungal Respiratory Superinfections in Invasively Ventilated COVID-19 Patients.
    J Med Virol. 2021 Dec 24. doi: 10.1002/jmv.27548.
    PubMed         Abstract available

  58. NEMR WA, Radwan NK
    J Med Virol. 2021 Dec 24. doi: 10.1002/jmv.27550.
    PubMed         Abstract available

  59. HE L, Zeng C, Zeng Y, Xu W, et al
    Antibody Responses of the First Wave of Survivors infected with SARS-CoV-2 One Year Ago.
    J Med Virol. 2021 Dec 25. doi: 10.1002/jmv.27551.

  60. DRAGIOTI E, Li H, Tsitsas G, Lee KH, et al
    A large scale meta-analytic atlas of mental health problems prevalence during the COVID-19 early pandemic.
    J Med Virol. 2021 Dec 27. doi: 10.1002/jmv.27549.
    PubMed         Abstract available

  61. RAHMANI S, Rezaei N
    Omicron (B.1.1.529) Variant: Development, Dissemination, and Dominance.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27563.
    PubMed         Abstract available

  62. LI A, Maier A, Carter M, Hugh Guan T, et al
    Omicron and S-Gene Target Failure Cases in the Highest COVID-19 Case Rate Region in Canada - December 2021.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27562.
    PubMed         Abstract available

  63. MOHAPATRA RK, Sarangi AK, Kandi V, Azam M, et al
    Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27561.
    PubMed         Abstract available

  64. WU K, Wu X, Wang W, Hong L, et al
    Epidemiology of influenza under the coronavirus disease 2019 pandemic in Nanjing, China.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27553.
    PubMed         Abstract available

  65. BASTUG A, Bodur H, Aydos O, Filazi N, et al
    The changing dynamics of neutralizing antibody response within ten months of SARS-CoV-2 infections.
    J Med Virol. 2021 Dec 30. doi: 10.1002/jmv.27544.
    PubMed         Abstract available

  66. XIAO F, Zhou Y, Zhang M, Chen D, et al
    Hyperglycemia and blood glucose deterioration are risk factors for severe COVID-19 with diabetes: a two-center cohort study.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27556.
    PubMed         Abstract available

  67. LIU W, Long X, Wan K, Yin M, et al
    The endogenous factors affecting the detection of serum SARS-CoV-2 IgG/IgM antibodies by ELISA.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27557.
    PubMed         Abstract available

  68. ITO K, Piantham C, Nishiura H
    Relative Instantaneous Reproduction Number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark.
    J Med Virol. 2021 Dec 30. doi: 10.1002/jmv.27560.
    PubMed         Abstract available

    J Travel Med

  69. DESHPANDE GR, Bhukya PL, Yadav PD, Salunke A, et al
    Comparison of neutralizing antibody response in first and second waves of SARS CoV-2 pandemic in India.
    J Travel Med. 2021 Dec 28. pii: 6485192. doi: 10.1093.
    PubMed         Abstract available


  70. KUEHN BM
    Influenza Vaccination Increased During the COVID-19 Pandemic.
    JAMA. 2021;326:2465.

  71. MASLO C, Friedland R, Toubkin M, Laubscher A, et al
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves.
    JAMA. 2021 Dec 30. pii: 2787776. doi: 10.1001/jama.2021.24868.

  72. SURAN M
    Expanding Localized Outreach to Combat COVID-19.
    JAMA. 2021;326:2463.

  73. SURAN M
    Autopsies Reveal Lung Damage Patterns From COVID-19.
    JAMA. 2021;326:2463.

  74. RUBIN R
    Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis.
    JAMA. 2021 Dec 29. pii: 2787758. doi: 10.1001/jama.2021.23557.

  75. OKIKE K, Chan PH, Navarro RA, Khatod MX, et al
    Hip Fracture Surgery Volumes Among Individuals 65 Years and Older During the COVID-19 Pandemic.
    JAMA. 2021 Dec 30. pii: 2787777. doi: 10.1001/jama.2021.23761.


    UK makes massive global health cuts.
    Lancet. 2021;397:1697.

  77. NASAR S
    Patrolling race and the UK's medical borders.
    Lancet. 2021;397:1702-1703.

  78. SAXENA SG, Godfrey T
    Catalysing needed change for health systems in the USA.
    Lancet. 2021;397:1705-1706.

  79. GAMALLIEL N, Saminarsih D, Taher A
    Indonesia's second wave crisis: medical doctors' political role is needed more than ever.
    Lancet. 2021;398:839-840.

  80. The Lancet Commission on water, sanitation and hygiene, and health.
    Lancet. 2021;398:1469-1470.

    Earthquake compounds Haiti's health challenges.
    Lancet. 2021;398:944-945.

  82. USHER AD
    Vaccine shortages prompt changes to COVAX strategy.
    Lancet. 2021;398:1474.

  83. KICKBUSCH I, Piselli D, Agrawal A, Balicer R, et al
    The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world.
    Lancet. 2021;398:1727-1776.

  84. ORMISTON CK, Williams F
    LGBTQ youth mental health during COVID-19: unmet needs in public health and policy.
    Lancet. 2021 Dec 22. pii: S0140-6736(21)02872.

    Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02834.

  86. HALPERIN SA, Ye L, MacKinnon-Cameron D, Smith B, et al
    Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02753.
    PubMed         Abstract available

  87. KING J, Ferraz OLM, Jones A
    Mandatory COVID-19 vaccination and human rights.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02873.

  88. RICHTER L, Ghent L, Issa G, Okengo L, et al
    What the ODA cuts mean for us.
    Lancet. 2021;397:1705.

  89. REINHART E, Dawes D, Maybank A
    Structural medicine: towards an economy of care.
    Lancet. 2021;397:1691-1693.

  90. MAKONI M
    African Medicines Agency to be established.
    Lancet. 2021;398:1475.

  91. HOLT E
    Media restrictions have "cost lives".
    Lancet. 2021;397:1695-1696.

  92. KIDD SA, Hajat S, Bezgrebelna M, McKenzie K, et al
    The climate change-homelessness nexus.
    Lancet. 2021;397:1693-1694.

    Lancet Infect Dis

    Do health-care workers need a COVID-19 vaccine booster?
    Lancet Infect Dis. 2022;22:20.

  94. SORIANO JB, Murthy S, Marshall JC, Relan P, et al
    A clinical case definition of post-COVID-19 condition by a Delphi consensus.
    Lancet Infect Dis. 2021 Dec 21. pii: S1473-3099(21)00703.
    PubMed         Abstract available

  95. BAST E, Tang F, Dahn J, Palacio A, et al
    Increased risk of hospitalisation and death with the delta variant in the USA.
    Lancet Infect Dis. 2021;21:1629-1630.

  96. BURKI T
    COVID-19 vaccine mandates in Europe.
    Lancet Infect Dis. 2022;22:27-28.

  97. LLIBRE JM, Martin-Iguacel R, Revollo B
    Practical measures for SARS-CoV-2 infection prevention - Authors' reply.
    Lancet Infect Dis. 2022;22:21.

    Practical measures for SARS-CoV-2 infection prevention.
    Lancet Infect Dis. 2022;22:20-21.

  99. ROMERO C, Diez JM, Gajardo R
    Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products-an update.
    Lancet Infect Dis. 2022;22:19.

  100. LALVANI A, Hakki S, Singanayagam A, Dunning J, et al
    Transmissibility of SARS-CoV-2 among fully vaccinated individuals - Authors' reply.
    Lancet Infect Dis. 2022;22:18-19.

  101. SHAPIRO AE, Bender Ignacio RA
    Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19.
    Lancet Infect Dis. 2021 Dec 23. pii: S1473-3099(21)00762.

  102. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.
    Lancet Infect Dis. 2021 Dec 23. pii: S1473-3099(21)00751.
    PubMed         Abstract available

  103. KUMAR A K A, Mishra N
    Mortality during the COVID-19 pandemic: the blind spots in statistics.
    Lancet Infect Dis. 2021 Dec 22. pii: S1473-3099(21)00767.

  104. GOOSSENS H, Derde L, Horby P, Bonten M, et al
    The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations.
    Lancet Infect Dis. 2021 Dec 21. pii: S1473-3099(21)00705.
    PubMed         Abstract available

  105. LEWNARD JA, Mahmud A, Narayan T, Wahl B, et al
    All-cause mortality during the COVID-19 pandemic in Chennai, India: an observational study.
    Lancet Infect Dis. 2021 Dec 22. pii: S1473-3099(21)00746.
    PubMed         Abstract available

    Transmissibility of SARS-CoV-2 among fully vaccinated individuals.
    Lancet Infect Dis. 2022;22:16.

  107. KO HHT
    Transmissibility of SARS-CoV-2 among fully vaccinated individuals.
    Lancet Infect Dis. 2022;22:17-18.

  108. KNOL MJ, Backer JA, de Melker HE, van den Hof S, et al
    Transmissibility of SARS-CoV-2 among fully vaccinated individuals.
    Lancet Infect Dis. 2022;22:16-17.

    MMWR Morb Mortal Wkly Rep

  109. HAUSE AM, Baggs J, Marquez P, Myers TR, et al
    COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1755-1760.
    PubMed         Abstract available

  110. HARRIS-MCCOY K, Lee VC, Munna C, Kim AA, et al
    Evaluation of a Test to Stay Strategy in Transitional Kindergarten Through Grade 12 Schools - Los Angeles County, California, August 16-October 31, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1773-1777.
    PubMed         Abstract available

  111. LUTRICK K, Rivers P, Yoo YM, Grant L, et al
    Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1761-1765.
    PubMed         Abstract available

  112. WANGA V, Gerdes ME, Shi DS, Choudhary R, et al
    Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1766-1772.
    PubMed         Abstract available

  113. JANSEN L, Tegomoh B, Lange K, Showalter K, et al
    Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster - Nebraska, November-December 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1782-1784.
    PubMed         Abstract available

  114. NEMOTO N, Dhillon S, Fink S, Holman EJ, et al
    Evaluation of Test to Stay Strategy on Secondary and Tertiary Transmission of SARS-CoV-2 in K-12 Schools - Lake County, Illinois, August 9-October 29, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1778-1781.
    PubMed         Abstract available

    N Engl J Med

  115. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Vaccination and the Omicron Variant.
    N Engl J Med. 2021;385:e102.

  116. MCGREW S, Taylor HA
    Adolescents, Parents, and Covid-19 Vaccination - Who Should Decide?
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMp2116771.

  117. NEMET I, Kliker L, Lustig Y, Zuckerman N, et al
    Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMc2119358.


  118. BUNDELL S, Howe N, Fox D, Baker N, et al
    Our podcast highlights of 2021.
    Nature. 2021 Dec 29. pii: 10.1038/d41586-021-03654.

    Researchers fear growing COVID vaccine hesitancy in developing nations.
    Nature. 2021 Dec 23. pii: 10.1038/d41586-021-03830.


    Missed shots.
    Science. 2021;374:1434-1435.
    PubMed         Abstract available

    Scientists see a 'really, really tough winter' with Omicron.
    Science. 2021;374:1421-1422.
    PubMed         Abstract available

  122. SCOTT L, Hsiao NY, Moyo S, Singh L, et al
    Track Omicron's spread with molecular data.
    Science. 2021;374:1454-1455.
    PubMed         Abstract available

    Travel Med Infect Dis

  123. SUWANTIKA AA, Dhamanti I, Suharto Y, Purba FD, et al
    The cost-effectiveness of social distancing measures for mitigating the COVID-19 pandemic in a highly-populated country: A case study in Indonesia.
    Travel Med Infect Dis. 2021;45:102245.
    PubMed         Abstract available

  124. BENAVIDES-MELO J, Rojas-Bautista L, Jaramillo-Arellano A, Montenegro-Coral FA, et al
    COVID-19 vaccination intention among Venezuelan migrant populations in Colombia, 2021.
    Travel Med Infect Dis. 2021 Dec 22:102250. doi: 10.1016/j.tmaid.2021.102250.

  125. RUI J, Wang Q, Lv J, Zhao B, et al
    The transmission dynamics of Middle East Respiratory Syndrome coronavirus.
    Travel Med Infect Dis. 2021;45:102243.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.